This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.
Favorite
2001
This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.
Favorite
2001
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Favorite
2001
This pamphlet discusses taking TB medicines, explains directly observed therapy, and the importance of taking all medications for the prescribed period of time.
Favorite
2002
This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.
Favorite
2002
This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB in DOTS-Plus projects.
Favorite
2003
This report presents recommendations for the treatment of tuberculosis.
Favorite
2003
This fact sheet, available online or via fax only, discusses TB treatment options for persons with HIV/AIDS, including dosage recommendations for HIV-infected adults and children. It also discusses adverse reactions and special situations such as extrapulmonary TB, TB in HIV-infected pregnant women, and drug-resistant TB.
Favorite
Infection Control and Occupational Health Workers
2003
This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the New Jersey Medical School Global Tuberculosis Institute. All of these patient education materials can be found on the following webpage: www.cdc.gov/tb/pubs/CulturalMaterials...
Favorite
Persons With LTBI
2005
This slide presentation with streaming audio, provides information on how to manage treatment of tuberculosis (TB). A pre and posttest, question and answer guide, printable PowerPoint slide file, and other useful resources are also included as supplemental reading materials.
Favorite
Medical and Nursing School Students
2006
This reference card includes information on the risk factors for TB infection and developing TB disease, primary evaluation of patients, determining the medical history of a TB suspect, essential anti-TB drugs (prescribed by TB services), an overview of adverse drug effects and their management, an algorithm for detecting and diagnosing pulmonary TB, and patient education and adherence.
Favorite
International Agencies
2006
This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the Northeastern National Tuberculosis Center. This booklet provides information on treatment for TB infection, treatment for TB disease, and how to stay on track with a medicine plan...
Favorite
Asian or Pacific Islander persons
Non-U.S.-born persons
2008
This pocket-size drug treatment card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in children, including dosages, daily and intermittent regimens, side effects, treatment information and visual depictions of first-line medications.
Favorite
2009
This pocket-size drug treatment information card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in adults, including dosages, daily and intermittent regimens, side effects, treatment information, and visual depictions of first-line medications.
Favorite
2009
This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with TB drugs.
Favorite
Nurses
Outreach Workers
Physicians
2010
